Shmerling James E. 4
4 · Biostage, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Shmerling James E.
Director
Transactions
- Purchase
Common Stock
2022-05-12$5.92/sh+16,892$100,001→ 16,892 total - Purchase
Warrants (right to buy)
2022-05-12+8,446→ 8,446 totalExercise: $8.88From: 2022-05-12Exp: 2027-05-12→ Common Stock (8,446 underlying)
Footnotes (1)
- [F1]On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 16,892 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 8,446 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $100,000.